Evaluation of folate receptor-alpha and other surface markers as potential targets for radionuclide therapy of ovarian cancer

Key Points

• Folate receptor-alpha is identified as a promising target for radionuclide therapy in ovarian cancer.
• This study highlights the importance of surface markers in tailoring cancer treatments, with a focus on radionuclide therapy.
• A comprehensive evaluation of surface markers shows how they can be utilized for effective targeted therapy options.
• These findings indicate the potential for developing targeted radionuclide therapies, warranting further investigation into their clinical applications.